19
IRUS Total
Downloads
  Altmetric

Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease

File Description SizeFormat 
Stock2020_Article_DefiningGeneticRiskFactorsForS.pdfPublished version274.62 kBAdobe PDFView/Open
Title: Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
Authors: Stock, CJW
De Lauretis, A
Visca, D
Daccord, C
Kokosi, M
Kouranos, V
Margaritopoulos, G
George, PM
Molyneaux, PL
Nihtyanova, S
Chua, F
Maher, TM
Ong, V
Abraham, DJ
Denton, CP
Wells, AU
Wain, LV
Renzoni, EA
Item Type: Journal Article
Abstract: Although several genetic associations with scleroderma (SSc) are defined, very little is known on genetic susceptibility to SSc-associated interstitial lung disease (SSc-ILD). A number of common polymorphisms have been associated with SSc-ILD, but most have not been replicated in separate populations. Four SNPs in IRF5, and one in each of STAT4, CD226 and IRAK1, selected as having been previously the most consistently associated with SSc-ILD, were genotyped in 612 SSc patients, of European descent, of whom 394 had ILD. The control population (n = 503) comprised individuals of European descent from the 1000 Genomes Project. After Bonferroni correction, two of the IRF5 SNPs, rs2004640 (OR (95% CI)1.30 (1.10-1.54), pcorr = 0.015) and rs10488631 (OR 1.48 (1.14-1.92), pcorr = 0.022), and the STAT4 SNP rs7574865 (OR 1.43 (1.18-1.73), pcorr = 0.0015) were significantly associated with SSc compared with controls. However, none of the SNPs were significantly different between patients with SSc-ILD and controls. Two SNPs in IRF5, rs10488631 (OR 1.72 (1.24-2.39), pcorr = 0.0098), and rs2004640 (OR 1.39 (1.11-1.75), pcorr = 0.03), showed a significant difference in allele frequency between controls and patients without ILD, as did STAT4 rs7574865 (OR 1.86 (1.45-2.38), pcorr = 6.6 × 10-6). A significant difference between SSc with and without ILD was only observed for STAT4 rs7574865, being less frequent in patients with ILD (OR 0.66 (0.51-0.85), pcorr = 0.0084). In conclusion, IRF5 rs2004640 and rs10488631, and STAT4 rs7574865 were significantly associated with SSc as a whole. Only STAT4 rs7574865 showed a significant difference in allele frequency in SSc-ILD, with the T allele being protective against ILD.Key points• We confirm the associations of the IRF5 SNPs rs2004640 and rs10488631, and the STAT4 SNP rs7574865, with SSc as a whole.• None of the tested SNPs were risk factors for SSc-ILD specifically.• The STAT4 rs7574865 T allele was protective against the development of lung fibrosis in SSc patients.• Further work is required to understand the genetic basis of lung fibrosis in association with scleroderma.
Issue Date: 1-Apr-2020
Date of Acceptance: 29-Dec-2019
URI: http://hdl.handle.net/10044/1/76603
DOI: 10.1007/s10067-019-04922-6
ISSN: 0770-3198
Publisher: Springer Verlag
Start Page: 1173
End Page: 1179
Journal / Book Title: Clinical Rheumatology
Volume: 39
Copyright Statement: © The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Sponsor/Funder: Action for Pulmonary Fibrosis
Versus Arthritis
The Scleroderma Society
British Lung Foundation
National Institute for Health Research
British Lung Foundation
Imperial College Healthcare NHS Trust- BRC Funding
Funder's Grant Number: n/a
20719
n/a
RG14-10
BRU 6279
C17-3
RDF04
Keywords: Science & Technology
Life Sciences & Biomedicine
Rheumatology
CD226
Genetic association
Genetics
IRAK1
IRF5
SSc-ILD
STAT4
IDIOPATHIC PULMONARY-FIBROSIS
SYSTEMIC-SCLEROSIS
FUNCTIONAL POLYMORPHISM
SUSCEPTIBILITY
CYCLOPHOSPHAMIDE
RS2004640
CD226
Genetic association
Genetics
IRAK1
IRF5
SSc-ILD
STAT4
CD226
Genetic association
Genetics
IRAK1
IRF5
SSc-ILD
STAT4
1103 Clinical Sciences
Arthritis & Rheumatology
Publication Status: Published
Conference Place: Germany
Online Publication Date: 2020-01-08
Appears in Collections:National Heart and Lung Institute
Faculty of Medicine